Early Introduction of Cenobamate in Uncontrolled Focal Epilepsy: Insights from a Structured Controversy
Abstract Introduction Drug-resistant focal epilepsy, as defined by the International League Against Epilepsy (ILAE), is characterized by the failure to achieve seizure control despite the use of at least two appropriately chosen and adequately dosed antiseizure medications (ASMs). This condition aff...
Saved in:
| Main Authors: | Angelo Labate, Claudio Liguori, Elena Tartara, Gemma Tumminelli, Annacarmen Nilo, Marta Piccioli, Filippo Dainese, Luigi Del Gaudio, Carlo Di Bonaventura |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Adis, Springer Healthcare
2025-06-01
|
| Series: | Neurology and Therapy |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s40120-025-00781-3 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Increase of Brivaracetam serum concentration with introduction of Cenobamate
by: Lena Bender, et al.
Published: (2025-04-01) -
Real‐world effectiveness and tolerability of cenobamate in drug‐resistant epilepsy: A retrospective analysis of the patients included into the Early Access Programs (EAP) in Germany, France, and United Kingdom
by: Sylvain Rheims, et al.
Published: (2025-06-01) -
Real-world utilization of Cenobamate as adjunct therapy in office-based neurology: practical tips and insights for titration
by: Patrick M. House, et al.
Published: (2025-06-01) -
A french real-world experience with cenobamate in patients with drug-resistant focal epilepsy: A retrospective observational study
by: Antoine Plaquevent, et al.
Published: (2025-09-01) -
Cost-effectiveness of cenobamate as a therapeutic alternative for the treatment of focal epilepsy in adults with inadequate seizure control
by: Martina Paoletti, et al.
Published: (2025-05-01)